NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Ansell Healthcare
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Ansell Limited to Acquire Barriersafe Solutions International - Ansell Limited announces that it has reached an agreement to acquire BarrierSafe Solutions International (“BarrierSafe”), a leading North American provider of single-use gloves, for a total consideration of approximately US$615 million [ASX: ANN] - Ansell
Ansell Limited to Acquire Barriersafe Solutions International

 

NewswireToday - /newswire/ - Melbourne, Victoria, Australia, 2013/11/26 - Ansell Limited announces that it has reached an agreement to acquire BarrierSafe Solutions International (“BarrierSafe”), a leading North American provider of single-use gloves, for a total consideration of approximately US$615 million [ASX: ANN] - Ansell.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Ansell Limited (ASX: ANN), a global leader in protection solutions, today announces that it has reached an agreement to acquire BarrierSafe Solutions International (“BarrierSafe”), a leading North American provider of single-use gloves, for a total consideration of approximately US$615 million, subject to certain adjustments (the “Acquisition"), from Odyssey Investment Partners and others. Founded in 1987, BarrierSafe has sales of approximately US$290 million per annum. With the Acquisition, Ansell further expands its position in the hand protection market in North America and continues to implement its strategy to create shareholder value through organic and acquisition driven growth.

The agreement is subject to U.S. anti-trust clearance and customary closing conditions. It is expected to complete during the first quarter of calendar year 2014.

The Acquisition and associated transaction costs will be funded by a committed debt facility of US$300 million as well as the raising of new equity through a fully-underwritten private placement of A$338 million (US$308 million[1]) and a portion of a non-underwritten share purchase plan (SPP) of up to A$100 million (US$91 million1) to all eligible shareholders in Australia and New Zealand.

“The acquisition of BarrierSafe is a rare opportunity to strengthen the position of Ansell in the core North American single-use glove market and will further enhance our position as the global leader in hand protection solutions,” said Magnus Nicolin, Chief Executive Officer and Managing Director at Ansell. “The acquisition represents another strategic move in fulfilling our growth objectives in target industry verticals and is consistent with our disciplined approach to mergers and acquisitions, with an EBITDA multiple similar to that paid by Ansell in other recent transactions. I am also delighted to confirm that BarrierSafe CEO Michael Mattos and COO/CFO Joseph Kubicek will become part of the Ansell leadership team on completion of the transaction, and I expect BarrierSafe senior management to play important roles in the success of the combined business going forward.”

BarrierSafe is the leading North American provider of single-use gloves to core Ansell growth verticals like Industrial, Auto Aftermarket, Emergency Medical Services, Dental and Life Sciences, all under the flagship brand Microflex®. BarrierSafe also manufactures and distributes a market leading range of Onguard™ branded protective footwear. BarrierSafe has approximately 250 employees in locations across North America and Southeast Asia.

[1] Assumes AUDUSD exchange rate of 0.91

Ansell expects to achieve significant cost synergies primarily from supply chain savings as well as increased revenue opportunities from cross-selling and vertical development.

On a normalised basis, excluding non-recurring costs (transaction costs and one-time integration expenses), the acquisition is expected to be accretive to EPS in the low-single digit % in F'14 and in the mid-single digit % in F'15.

After including non-recurring costs the acquisition is expected to be marginally dilutive to reported EPS in F'14 and accretive to reported EPS by a low-to-mid-single digit % in F'15.

UBS is acting as the sole financial adviser to Ansell, and Drinker Biddle & Reath LLP and Baker & McKenzie are its legal advisers.

Ansell (ansell.com) will host an investor webcast to discuss further details of the acquisition on 26 November 2013 at 10:30am (AEDT) / 25 November 2013 at 6:30pm (US EST), and 11.30pm (London GMT). To access this webcast, please refer to the following information:

Primary dial-in #'s: US and Canada: 866 3188 616 (toll free); Australia: 1800 002 971 (toll free) / +61 (0) 2 8223 9376
Country specific international dial-in #’s: btconferencing.com/.
Participant passcode: 21707471

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Ansell Healthcare

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Ansell Limited to Acquire Barriersafe Solutions International

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Press Office - Ansell.com 
+46 708 157186 news[.]ansell.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Ansell Healthcare securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Ansell Healthcare / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program
BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals Finds Frost & Sullivan
New Bruker NMR Life Science Research Solutions Enable Functional Structural and Cellular Biology Research
Bruker Corporation Launches A New VIP-HESI Ion Source
US National Science Foundation’s (NSF) Division of Biological Infrastructure Announced An Award to Create A Novel ‘Network for Advanced NMR’ (NAN)
Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe Finds Frost & Sullivan
Bruker Launches TimsTOF TrueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen TimsTOF Pro 2 with Unprecedented Proteomic Depth

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow, Inc.





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)